Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AML Treatment in Untreated Adult Patients According to EORTC-GIMEMA Protocols AML8 and AML10

NCT00449319 is registered in ClinicalTrials.gov with Gruppo Italiano Malattie EMatologiche dell'Adulto as lead sponsor.

NCT NCT00449319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00449319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AML Treatment in Untreated Adult Patients According to EORTC-GIMEMA Protocols AML8 and AML10
Lead sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 1998
Completion date
July 31, 2018
Enrollment
Not reported
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, myelocytic, acute